134 related articles for article (PubMed ID: 8556974)
41. Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial.
Mooney ME; Herin DV; Specker S; Babb D; Levin FR; Grabowski J
Drug Alcohol Depend; 2015 Aug; 153():94-103. PubMed ID: 26116930
[TBL] [Abstract][Full Text] [Related]
42. Mazindol and cocaine addiction in schizophrenia.
Seibyl JP; Brenner L; Krystal JH; Johnson R; Charney DS
Biol Psychiatry; 1992 Jun; 31(11):1179-81. PubMed ID: 1525287
[No Abstract] [Full Text] [Related]
43. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
44. Carbamazepine treatment for cocaine dependence.
Cornish JW; Maany I; Fudala PJ; Neal S; Poole SA; Volpicelli P; O'Brien CP
Drug Alcohol Depend; 1995 Jun; 38(3):221-7. PubMed ID: 7555622
[TBL] [Abstract][Full Text] [Related]
45. Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics.
Miller NS; Summers GL; Gold MS
J Addict Dis; 1993; 12(1):25-35. PubMed ID: 8381028
[TBL] [Abstract][Full Text] [Related]
46. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
Konstenius M; Jayaram-Lindström N; Beck O; Franck J
Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
[TBL] [Abstract][Full Text] [Related]
47. Relationships among physiological and self-report responses produced by cocaine-related cues.
Robbins SJ; Ehrman RN; Childress AR; O'Brien CP
Addict Behav; 1997; 22(2):157-67. PubMed ID: 9113211
[TBL] [Abstract][Full Text] [Related]
48. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
49. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
[TBL] [Abstract][Full Text] [Related]
50. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
51. Effects of mazindol in two patients with Prader-Willi syndrome.
Itoh M; Koeda T; Ohno K; Takeshita K
Pediatr Neurol; 1995 Nov; 13(4):349-51. PubMed ID: 8771175
[TBL] [Abstract][Full Text] [Related]
52. Mr R: a case study of withdrawal.
Dennison SJ
Behav Med; 1992; 18(3):139-40. PubMed ID: 1330103
[TBL] [Abstract][Full Text] [Related]
53. Imipramine for the treatment of cocaine and methamphetamine dependence.
Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
J Addict Dis; 1994; 13(4):201-16. PubMed ID: 7734470
[TBL] [Abstract][Full Text] [Related]
54. AN 448 Sandoz (Mazindol) in the treatment of obesity.
Wallace AG
Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
[TBL] [Abstract][Full Text] [Related]
55. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
56. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence.
Tennant FS; Tarver AL
NIDA Res Monogr; 1984; 55():159-63. PubMed ID: 6443373
[TBL] [Abstract][Full Text] [Related]
57. Acute treatment of alcohol and cocaine emergencies.
Taylor WA; Slaby AE
Recent Dev Alcohol; 1992; 10():179-91. PubMed ID: 1589601
[TBL] [Abstract][Full Text] [Related]
58. Mazindol: its efficacy and mode of action in generating weight loss.
Johnson WG; Hughes JR
Addict Behav; 1979; 4(3):237-44. PubMed ID: 495247
[No Abstract] [Full Text] [Related]
59. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
60. Carbamazepine and cocaine-cue reactivity.
Hersh D; Bauer LO; Kranzler HR
Drug Alcohol Depend; 1995 Oct; 39(3):213-21. PubMed ID: 8556970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
